Assessment of (18)F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy

IMPORTANCE: Progressive supranuclear palsy (PSP) is a 4-repeat tauopathy. Region-specific tau aggregates establish the neuropathologic diagnosis of definite PSP post mortem. Future interventional trials against tau in PSP would strongly benefit from biomarkers that support diagnosis. OBJECTIVE: To i...

Descripción completa

Detalles Bibliográficos
Autores principales: Brendel, Matthias, Barthel, Henryk, van Eimeren, Thilo, Marek, Ken, Beyer, Leonie, Song, Mengmeng, Palleis, Carla, Gehmeyr, Mona, Fietzek, Urban, Respondek, Gesine, Sauerbeck, Julia, Nitschmann, Alexander, Zach, Christian, Hammes, Jochen, Barbe, Michael T., Onur, Oezguer, Jessen, Frank, Saur, Dorothee, Schroeter, Matthias L., Rumpf, Jost-Julian, Rullmann, Michael, Schildan, Andreas, Patt, Marianne, Neumaier, Bernd, Barret, Olivier, Madonia, Jennifer, Russell, David S., Stephens, Andrew, Roeber, Sigrun, Herms, Jochen, Bötzel, Kai, Classen, Joseph, Bartenstein, Peter, Villemagne, Victor, Levin, Johannes, Höglinger, Günter U., Drzezga, Alexander, Seibyl, John, Sabri, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341407/
https://www.ncbi.nlm.nih.gov/pubmed/33165511
http://dx.doi.org/10.1001/jamaneurol.2020.2526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341407/
https://www.ncbi.nlm.nih.gov/pubmed/33165511
http://dx.doi.org/10.1001/jamaneurol.2020.2526

Ejemplares similares